Monday, 22 June, 2026г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

What Does the Future Hold for the SGLT2-Inhibitor Class?

What Does the Future Hold for the SGLT2-Inhibitor Class?У вашего броузера проблема в совместимости с HTML5
Robert Henry, MD, Professor of Medicine at the University of San Diego, California, discusses abstracts presented at the American Diabetes Association's 71st Scientific Sessions and provides his perspective on the future of this class of diabetes medication.
Мой аккаунт